Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.

Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Christensen JH, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV.

Clin Cancer Res. 2019 Aug 22. doi: 10.1158/1078-0432.CCR-19-1337. [Epub ahead of print]

PMID:
31439577
2.

Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins.

Traynor S, Møllegaard NE, Jørgensen MG, Brückmann NH, Pedersen CB, Terp MG, Johansen S, Dejardin J, Ditzel HJ, Gjerstorff MF.

Nucleic Acids Res. 2019 Jul 26;47(13):6668-6684. doi: 10.1093/nar/gkz396.

3.

Photodynamic therapy for cancer: Role of natural products.

Mansoori B, Mohammadi A, Amin Doustvandi M, Mohammadnejad F, Kamari F, Gjerstorff MF, Baradaran B, Hamblin MR.

Photodiagnosis Photodyn Ther. 2019 Jun;26:395-404. doi: 10.1016/j.pdpdt.2019.04.033. Epub 2019 May 4. Review.

PMID:
31063860
4.

HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancy.

Mansoori B, Mohammadi A, Asadzadeh Z, Shirjang S, Minouei M, Abedi Gaballu F, Shajari N, Kazemi T, Gjerstorff MF, Duijf PHG, Baradaran B.

J Cell Physiol. 2019 Aug;234(10):17714-17726. doi: 10.1002/jcp.28397. Epub 2019 Mar 1.

PMID:
30825204
5.

miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancer.

Mansoori B, Mohammadi A, Gjerstorff MF, Shirjang S, Asadzadeh Z, Khaze V, Holmskov U, Kazemi T, Duijf PHG, Baradaran B.

J Cell Physiol. 2019 Feb 11. doi: 10.1002/jcp.28263. [Epub ahead of print]

PMID:
30741415
6.

Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers.

Hansen SV, Traynor S, Ditzel HJ, Gjerstorff MF.

PLoS One. 2018 Oct 10;13(10):e0205461. doi: 10.1371/journal.pone.0205461. eCollection 2018.

7.

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.

Elias D, Vever H, Lænkholm AV, Gjerstorff MF, Yde CW, Lykkesfeldt AE, Ditzel HJ.

Oncogene. 2018 Oct;37(41):5585-5586. doi: 10.1038/s41388-018-0495-6.

PMID:
30242243
8.

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.

Kirkin AF, Dzhandzhugazyan KN, Guldberg P, Fang JJ, Andersen RS, Dahl C, Mortensen J, Lundby T, Wagner A, Law I, Broholm H, Madsen L, Lundell-Ek C, Gjerstorff MF, Ditzel HJ, Jensen MR, Fischer W.

Nat Commun. 2018 Mar 6;9(1):785. doi: 10.1038/s41467-018-03217-9.

9.

Epigenetic Reprogramming of Pericentromeric Satellite DNA in Premalignant and Malignant Lesions.

Brückmann NH, Pedersen CB, Ditzel HJ, Gjerstorff MF.

Mol Cancer Res. 2018 Mar;16(3):417-427. doi: 10.1158/1541-7786.MCR-17-0477. Epub 2018 Jan 12.

10.

Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic Instability.

Nielsen AY, Gjerstorff MF.

Int J Mol Sci. 2016 Jun 6;17(6). pii: E890. doi: 10.3390/ijms17060890. Review.

11.

The role of GAGE cancer/testis antigen in metastasis: the jury is still out.

Gjerstorff MF, Terp MG, Hansen MB, Ditzel HJ.

BMC Cancer. 2016 Jan 8;16:7. doi: 10.1186/s12885-015-1998-y.

12.

Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer.

Maheswaran E, Pedersen CB, Ditzel HJ, Gjerstorff MF.

PLoS One. 2015 Aug 7;10(8):e0134967. doi: 10.1371/journal.pone.0134967. eCollection 2015.

13.

Oncogenic cancer/testis antigens: prime candidates for immunotherapy.

Gjerstorff MF, Andersen MH, Ditzel HJ.

Oncotarget. 2015 Jun 30;6(18):15772-87. Review.

14.

Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.

Greve KB, Lindgreen JN, Terp MG, Pedersen CB, Schmidt S, Mollenhauer J, Kristensen SB, Andersen RS, Relster MM, Ditzel HJ, Gjerstorff MF.

Mol Oncol. 2015 Feb;9(2):437-49. doi: 10.1016/j.molonc.2014.09.001. Epub 2014 Oct 6.

15.

SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression.

Gjerstorff MF, Relster MM, Greve KB, Moeller JB, Elias D, Lindgreen JN, Schmidt S, Mollenhauer J, Voldborg B, Pedersen CB, Brückmann NH, Møllegaard NE, Ditzel HJ.

Nucleic Acids Res. 2014 Oct;42(18):11433-46. doi: 10.1093/nar/gku852. Epub 2014 Sep 23.

16.

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.

Elias D, Vever H, Lænkholm AV, Gjerstorff MF, Yde CW, Lykkesfeldt AE, Ditzel HJ.

Oncogene. 2015 Apr 9;34(15):1919-27. doi: 10.1038/onc.2014.138. Epub 2014 Jun 2. Erratum in: Oncogene. 2018 Oct;37(41):5585-5586.

PMID:
24882577
17.

SSX2-4 expression in early-stage non-small cell lung cancer.

Greve KB, Pøhl M, Olsen KE, Nielsen O, Ditzel HJ, Gjerstorff MF.

Tissue Antigens. 2014 May;83(5):344-9. doi: 10.1111/tan.12340. Epub 2014 Mar 20.

PMID:
24645645
18.

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.

Gjerstorff MF, Pøhl M, Olsen KE, Ditzel HJ.

BMC Cancer. 2013 Oct 8;13:466. doi: 10.1186/1471-2407-13-466.

19.

Limited SP17 expression within tumors diminishes its therapeutic potential.

Gjerstorff MF, Ditzel HJ.

Tissue Antigens. 2012 Dec;80(6):523-7. doi: 10.1111/tan.12015.

PMID:
23137323
20.

GAGE cancer-germline antigens are recruited to the nuclear envelope by germ cell-less (GCL).

Gjerstorff MF, Rösner HI, Pedersen CB, Greve KB, Schmidt S, Wilson KL, Mollenhauer J, Besir H, Poulsen FM, Møllegaard NE, Ditzel HJ.

PLoS One. 2012;7(9):e45819. doi: 10.1371/journal.pone.0045819. Epub 2012 Sep 20.

21.

Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum.

Schoennemann KR, Bjerregaard JK, Hansen TP, De Stricker K, Gjerstorff MF, Jensen HA, Vestermark LW, Pfeiffer P.

Gastric Cancer. 2011 Aug;14(3):219-25. doi: 10.1007/s10120-011-0031-7. Epub 2011 Mar 17.

PMID:
21409520
22.

Expression, purification and characterization of the cancer-germline antigen GAGE12I: a candidate for cancer immunotherapy.

Gjerstorff MF, Besir H, Larsen MR, Ditzel HJ.

Protein Expr Purif. 2010 Oct;73(2):217-22. doi: 10.1016/j.pep.2010.05.010. Epub 2010 May 27.

PMID:
20546897
23.

Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.

Gjerstorff MF, Burns J, Ditzel HJ.

Expert Opin Biol Ther. 2010 Jul;10(7):1061-75. doi: 10.1517/14712598.2010.485188. Review.

PMID:
20420535
24.

Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation.

Gjerstorff MF, Harkness L, Kassem M, Frandsen U, Nielsen O, Lutterodt M, Møllgård K, Ditzel HJ.

Hum Reprod. 2008 Oct;23(10):2194-201. doi: 10.1093/humrep/den262. Epub 2008 Jul 8.

PMID:
18611917
25.

An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members.

Gjerstorff MF, Ditzel HJ.

Tissue Antigens. 2008 Mar;71(3):187-92. doi: 10.1111/j.1399-0039.2007.00997.x. Epub 2008 Jan 7. Review.

PMID:
18179644
26.

MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development.

Gjerstorff MF, Kock K, Nielsen O, Ditzel HJ.

Hum Reprod. 2007 Apr;22(4):953-60. Epub 2007 Jan 5.

PMID:
17208940
28.

Identification of genes with altered expression in medullary breast cancer vs. ductal breast cancer and normal breast epithelia.

Gjerstorff MF, Benoit VM, Laenkholm AV, Nielsen O, Johansen LE, Ditzel HJ.

Int J Oncol. 2006 Jun;28(6):1327-35.

PMID:
16685433

Supplemental Content

Loading ...
Support Center